Parkinson disease is characterized by dopaminergic cell loss in the substantia nigra of the
midbrain. There are various imaging markers for Parkinson disease. Recent advances in …

The differential diagnosis of parkinsonian syndromes is considered one of the most
challenging in neurology and error rates in the clinical diagnosis can be high even at …

ABSTRACT PSP is a pathologically defined neurodegenerative tauopathy with a variety of
clinical presentations including typical Richardson's syndrome and other variant PSP …

Background Supervised machine learning has been proposed as a revolutionary approach
for identifying sensitive medical image biomarkers (or combination of them) allowing for …

Background: Neurocognitive impairment remains prevalent in HIV-infected (HIV+)
individuals despite highly active antiretroviral therapy (HAART). We assessed the impact of …

In vivo quantification of β-amyloid deposition using positron emission tomography is
emerging as an important procedure for the early diagnosis of the Alzheimer's disease and …

Multiple system atrophy (MSA) is a fatal adult‐onset neurodegenerative disorder of
uncertain etiology, clinically manifesting with autonomic failure associated with …

Conventional magnetic resonance imaging (cMRI) is often used to aid the diagnosis of
progressive supranuclear palsy (PSP) and multiple system atrophy (MSA), but its ability to …

Background/Objective Parkinson's disease (PD) and the atypical parkinsonian syndromes
multiple system atrophy (MSA), progressive supranuclear palsy (PSP) and corticobasal …

Background Clinical differentiation of parkinsonian syndromes is still challenging. Objectives
A fully automated method for quantitative MRI analysis using atlas‐based volumetry …